Elicio Therapeutics, Inc. — Form D

Elicio Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-23. The offering totals $40.0M, of which $6.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Victor R GanziDirectorSan Francisco, CA
Itzhak D GoldbergDirectorUniondale, NY
Allen R NissensonDirectorSan Francisco, CA
Gil R OmennDirectorSan Francisco, CA
Jay R VenkatesanDirectorSan Francisco, CA
Karen R WilsonDirectorSan Francisco, CA
Itzhak D GoldbergExecutive OfficerUniondale, NY
Jay R VenkatesanExecutive OfficerSan Francisco, CA
Yekaterina ChudnovskyDirectorLOS ANGELES, CA
Karen WilsonDirectorBoston, MA
Christopher HaqqExecutive OfficerBoston, MA
Jay VenkatesanDirectorBoston, MA
Carol AsheDirectorBoston, MA
Brian PiekosExecutive OfficerBoston, MA
Robert ConnellyDirectorBoston, MA
Robert ConnellyExecutive OfficerBoston, MA
Allen NissensonDirectorBoston, MA
Robert RuffoloDirectorBoston, MA
Peter DeMuthExecutive OfficerBoston, MA
Julian AdamsDirectorBoston, MA
Michael R YaminDirectorUniondale, NY
Jay D VenkatesanDirectorUniondale, NY
Jay D VenkatesanExecutive OfficerUniondale, NY
Michael D YaminDirectorUniondale, NY

Other filings by this issuer (7)

FiledFormOfferingSold
2024-03-29D$6.0M$6.0M
2024-01-05D$7.0M$7.0M
2020-01-27D$12.0M$1.0M
2020-01-13D$12.0M$6.1M
2018-07-17D$35.0M$15.4M
2018-07-17D$5.4M$5.4M
2015-02-20D$15.0M$4.4M

More